Eli Lilly stock in focus before earnings after Novo warns on obesity-drug price squeeze

Eli Lilly stock in focus before earnings after Novo warns on obesity-drug price squeeze

Eli Lilly shares fell 0.5% to $998.50 in premarket trading Wednesday after a 4% drop Tuesday, following Novo Nordisk’s warning of up to a 13% drop in 2026 sales and profits. Novo cut prices and launched an oral Wegovy, while Lilly plans to cap higher-dose obesity drug prices at $399 per month for repeat cash buyers. Investors await Lilly’s Q4 results and comments on pricing and competition.
Adobe stock slips again: ADBE hit by Piper Sandler downgrade as AI disruption fears linger

Adobe stock slips again: ADBE hit by Piper Sandler downgrade as AI disruption fears linger

Adobe shares fell 0.6% to $270.20 in Wednesday’s premarket after a 7.3% drop Tuesday. Piper Sandler downgraded the stock to neutral and cut its price target to $330, citing weaker demand for licenses. The selloff followed Anthropic’s launch of new AI plug-ins, raising concerns over competition. Adobe’s earnings call is scheduled for March 12.
Bajaj Finserv profit stalls as India’s Q3 results rush hits Trent, Tata Power next

Bajaj Finserv profit stalls as India’s Q3 results rush hits Trent, Tata Power next

Bajaj Finserv’s December-quarter profit was nearly flat at 2,229 crore rupees, despite a 24% jump in revenue to 39,708 crore. Over 140 Indian firms, including Tata Power and Trent, are reporting earnings today. Markets steadied after recent gains, as IT stocks fell sharply. Emcure Pharmaceuticals’ profit rose 50%, while Westlife FoodWorld’s profit dropped 85%.
Enphase Energy stock jumps 23% premarket after outlook; tariffs and tax-credit clock back in focus

Enphase Energy stock jumps 23% premarket after outlook; tariffs and tax-credit clock back in focus

Enphase Energy shares jumped 23% to $45.98 in premarket trading after reporting Q4 revenue of $343.3 million and forecasting Q1 revenue between $270 million and $300 million. U.S. “sell-through” demand rose 21% from the previous quarter, while European revenue fell 29%. BMO raised its rating to “market perform” and set a $41 price target.
Chipotle stock eyes a volatile open after flat 2026 sales outlook and menu price hike plan

Chipotle stock eyes a volatile open after flat 2026 sales outlook and menu price hike plan

Chipotle shares rose 1.7% in premarket trading Wednesday after a 7% drop on its flat 2026 sales outlook and plans for a 1%–2% menu price hike. Fourth-quarter revenue reached about $3.0 billion, with comparable sales down 2.5% and transactions falling 3.2%. Restaurant-level operating margin dropped to 23.4% from 24.8%. Chipotle opened 132 new restaurants in the quarter.
SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

Super Micro Computer raised its fiscal 2026 revenue forecast to at least $40 billion, up from $36 billion. Shares edged up 0.1% to $29.67 premarket after December-quarter sales hit $12.7 billion, but gross margin fell to 6.3% from 9.3%. Management cited tariffs, memory shortages, and rising costs as margin pressures. The company projects at least $12.3 billion in sales for the March quarter.
Novo Nordisk stock price sinks nearly 18% as 2026 outlook jolts Wegovy trade

Novo Nordisk stock price sinks nearly 18% as 2026 outlook jolts Wegovy trade

Novo Nordisk shares fell about 18% in Copenhagen after the company warned of a possible 5–13% drop in 2026 sales and profit, citing U.S. price cuts and rising competition. The drugmaker faces pressure from cheaper copycat obesity drugs and a leadership change in its U.S. unit set for Feb. 5. U.S.-listed shares dropped 14.2% Tuesday.
Fresnillo share price dips today after a 6% jump as gold rebounds again — what’s next for FRES.L

Fresnillo share price dips today after a 6% jump as gold rebounds again — what’s next for FRES.L

Fresnillo shares slipped 0.3% to 3,889 pence in early London trading Wednesday, pulling back after a 6.4% surge on Tuesday. Gold and silver prices rose sharply amid U.S.-Iran tensions, while investors awaited Fresnillo’s March 3 results and focused on its trimmed 2026 production outlook. JPMorgan cut its price target to 4,500 pence but kept an “overweight” rating.
AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD shares fell 7.6% in premarket trading Wednesday after the company forecast a sequential revenue decline and projected first-quarter sales near $9.8 billion. The outlook included $100 million in MI308 AI chip sales to China, with management citing U.S. export controls as a key uncertainty. Data-center revenue rose 39% to $5.4 billion last quarter, but investors focused on AMD’s 55% adjusted gross margin versus Nvidia’s higher target.
1 87 88 89 90 91 2,709

Stock Market Today

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

7 February 2026
Singapore, Feb 7, 2026, 15:29 SGT — Market closed. Jardine Matheson Holdings fell 2.4% on Friday to close at $75.71 in its U.S. dollar counter on the Singapore Exchange, after trading between $75.30 and $78.83. About 293,900 shares changed hands, compared with 410,700 a day earlier. (Yahoo Finance) The move landed as regional markets cooled on a tech-led selloff and broader de-risking. Singapore’s shares fell 0.8% on the day, while investors tracked turbulence tied to U.S. tech and fresh debate over how quickly new AI tools could reshape software and services. “With U.S. tech wobbling, sentiments tend to trickle over
CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Go toTop